Nevro Corp

226 articles about Nevro Corp

• Nevro Announces Director Appointment - Aug 31, 2021

  8/31/2021

  Nevro Corp., a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, announced that Sri Kosaraju has been appointed as a member of the Board of Directors, effective August 31, 2021.

• Nevro to Present at Baird 2021 Global Healthcare Conference

  8/26/2021

  Nevro Corp. announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 10:50 am Eastern Time / 7:50 am Pacific Time.

• Nevro to Present at Morgan Stanley 19th Annual Global Healthcare Conference

  8/25/2021

  Nevro Corp. announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 11:45 am Eastern Time / 8:45 am Pacific Time.

• Nevro to Present at Wells Fargo Virtual Healthcare Conference

  8/23/2021

  Nevro Corp. announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the Wells Fargo Virtual Healthcare Conference on Friday, September 10, 2021 at 8:00 am Eastern Time / 5:00 am Pacific Time.

• Nevro Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 Guidance

  8/4/2021

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, reported its financial results for the second quarter ended June 30, 2021 and provided third quarter of 2021 guidance.

• Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)

  7/19/2021

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced receipt of FDA approval of its Senza® System for the treatment of chronic pain associated with Painful Diabetic Neuropathy.

• Nevro to Report Second Quarter 2021 Financial Results

  7/7/2021

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that the company will report its financial results for the second quarter ended June 30, 2021 after the market closes on August 4, 2021.

• Nevro Announces SENZA-PDN Clinical Data Presentation at the American Diabetes Association 81st Scientific Sessions

  6/22/2021

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that data from the SENZA Painful Diabetic Neuropathy Randomized Controlled Trial will be presented at the American Diabetes Association 81st Scientific Sessions virtual meeting, June 25-29, 2021.

• Nevro Announces SENZA-NSRBP Clinical Data Presentation at the American Society of Interventional Pain Physicians 23rd Annual Meeting

  6/22/2021

  Nevro Corp. announced that data from the SENZA Non-Surgical Refractory Back Pain Randomized Controlled Trial will be presented at the American Society of Interventional Pain Physicians 23rd annual meeting to be held in person from June 24-26, 2021 at the Hilton New Orleans Riverside in New Orleans, Louisiana.

• Nevro to Host Virtual Analyst & Investor Briefing

  6/14/2021

  Nevro Corp. today announced it will host an analyst & investor briefing from the American Diabetes Association 81st Scientific Sessions on Friday, June 25, 2021, beginning at 3:30 pm PT / 6:30 pm ET.

• Nevro Reports First Quarter 2021 Financial Results and Updates 2021 Guidance

  5/5/2021

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, reported its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance.

• Nevro to Present at UBS Global Healthcare Virtual Conference

  4/27/2021

   Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro's Chairman, CEO and President, will present at the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 4:00 pm Eastern Time / 1:00 pm Pacific Time.

• Nevro Appoints Jon R. Shear as Vice President, Corporate Development

  4/19/2021

  Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Jon Shear to the newly created position of Vice President, Corporate Development, effective immediately.  

• Nevro to Present at BofA Securities 2021 Virtual Health Care Conference

  4/13/2021

  Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro's Chairman, CEO and President, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 2:00 pm Eastern Time / 11:00 am Pacific Time.

• Nevro to Report First Quarter 2021 Financial Results

  4/7/2021

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that the company will report its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021.

• Nevro Announces Publication Of Landmark SENZA-PDN Clinical Trial Results In JAMA Neurology

  4/5/2021

  Level I Randomized Clinical Trial Demonstrates Significantly Improved and Sustained Outcomes with 10 kHz Spinal Cord Stimulation Patients Suffering from Painful Diabetic Neuropathy Experienced Substantial, Sustained Pain Relief and Improved Health-Related Quality of Life

• Nevro to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference

  2/1/2021

   Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro's Chairman, CEO and President will present at 2021 Healthcare Services

• Nevro to Present at 10th Annual SVB Leerink Global Healthcare Conference

  2/1/2021

   Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro's Chairman, CEO and President, will present at 10th Annual SVB Leerink Conference

• Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results

  1/27/2021

  Nevro Company to Host Conference Call on Wednesday, February 24, 2021, at 1:30 pm PT / 4:30 pm ET

• Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting

  1/14/2021

   Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the company's HF10® therapy for patients with chronic pain.  Results will be presented at the 2021 North Amer